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Abstract
Purpose—We assessed whether accuracy of self-reported screening for colorectal cancer (CRC)
varied by respondent characteristics or healthcare utilization.
Methods—From 2005 to 2007, 857 respondents aged 51 – 74 were recruited from a multi-
specialty medical group practice to answer a questionnaire about their CRC screening (CRCS)
behaviors. Self-reports were compared with administrative and medical records to assess
concordance, sensitivity, specificity, and report-to-records ratios for overall CRCS (fecal occult
blood test, sigmoidoscopy, and/or colonoscopy).
Results—Concordance was good (≥0.8 to <0.9) or fair (≥0.7 to <0.8) for most subgroups;
respondents with >5 visits outside the clinic had poor (<0.7) concordance. Sensitivity estimates
were mostly excellent (≥0.9) or good but poor for respondents whose healthcare provider did not
advise a specific CRCS test. Specificity was poor for the following respondents: 65+ years, males,
college graduates, family history of CRC, >5 visits outside of the clinic, or whose healthcare
provider advised a specific CRCS test. Respondents 65+ years and with >5 outside visits over-
reported CRCS.
Conclusions—With few exceptions, self-reports of CRCS in an insured population is
reasonably accurate across subgroups. More work is needed to replicate these findings in diverse
settings and populations to better understand subgroup differences and improve measures of
CRCS.
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1. INTRODUCTION
Although colorectal cancer screening (CRCS) rates are increasing [1], there is still room for
improvement if we are to achieve Healthy People 2010 goals [2] and eliminate disparities.
Monitoring adherence to guidelines enables us to assess progress towards meeting these
goals and to identify screening disparities for population subgroups [2]. Adherence to CRCS
guidelines is often assessed using self-reported data, in part, because of the time, cost, and
NIH Public Access
Author Manuscript
Open J Epidemiol. Author manuscript; available in PMC 2013 September 09.
Published in final edited form as:













limited access to medical records [3]. Increased reliance on self-reports underscores the need
for accurate measures of adherence [3,4].
Although a number of studies have assessed agreement between self-reported CRCS and
administrative data or medical records [5–19], fewer have examined sub group differences
in accuracy [5,6,8–12,15,16,19], and- most were limited to socio-demographic
characteristics.
No studies have examined whether healthcare utilization factors, such as the number of
visits to a healthcare provider, is associated with accuracy of self-reported CRCS.
Identifying subgroup differences in the accuracy of self-reported CRCS may assist in the
interpretation of prevalence estimates from survey data and the results of behavioral
interventions. Understanding differences also may be useful in guiding clinical decision-
making and improving patient-physician communication about CRCS.
We used data from a randomized controlled trial designed to evaluate the reliability and
validity of a standardized self-report questionnaire of CRCS behaviors to examine whether
the accuracy of self-report measures of CRCS behavior varied by respondent characteristics
and healthcare utilization.
2. MATERIALS AND METHODS
2.1. Study Setting and Sample Selection
A questionnaire, developed by one of the authors (SWV) in collaboration with scientists at
the National Cancer Institute (NCI) and the Centers for Disease Control and Prevention
(CDC) [4,12], was evaluated for reliability and validity using three modes of survey
administration mail, telephone, and face-to-face [13]. Study participants were men and
women, 51 to 74 years old, who were primary care patients for at least 5 years at a large
multispecialty medical group practice in Houston, Texas [13]. Patients with a prior history
of CRC were excluded. From 2005 to 2007, 1004 patients were randomized to mail,
telephone, or face- to-face mode of survey administration. Of these, 857 completed a
baseline survey and were included in this analysis. Additional details about recruitment,
eligibility, study design and study procedures are described elsewhere [13]. The study
protocol was approved by the University of Texas Health Science Center at Houston
Committee for Protection of Human Subjects.
2.2. Measures
Adherence to CRCS guidelines was defined as: a fecal occult blood test (FOBT) within the
past year, flexible sigmoidoscopy within the past 5 years, or colonoscopy within the past 5
years. For FOBT and sigmoidoscopy, these recommendations are the same as the American
Cancer Society (ACS) guidelines in effect at the time of the study [20]. Instead of
colonoscopy within the past 10 years per ACS guidelines, we restricted the measure to
within the past 5 years to match our eligibility criteria. This ensured a sufficient number of
patients and reduced the likelihood of receiving CRCS from an outside provider.
Self-reports were compared to a combined database of administrative and medical records
(referred to as the combined medical record). Type of tests and dates of each test were
abstracted from the combined medical record. Inter-rater agreement was assessed for three
pairs of raters for 81 patients. For the most recent test within guidelines, agreement was 98%
(kappa = 0.96). For all tests within the past 5 years, agreement was 91% (kappa = 0.89). If a
patient reported a test from an outside provider that was not recorded in the combined
medical record, we contacted the provider to confirm the report [13]. Of the 30 providers
White et al. Page 2













contacted, 23 provided the requested information, and this information was added to the
database.
We assessed the following characteristics through the survey: age (categorized as 51 – 64,
65+); gender (male, female); race/ethnicity (non-Hispanic white, African American, other);
marital status (not married, married/living with partner); education (<high school diploma/
General Equivalency Diploma (GED), some college, college+); family history of cancer
(yes, no); number of physician visits in the past 5 years at the clinic (0 – 5, >5); number of
physician visits in the past 5 years outside of the clinic (0 – 5, >5); and whether their
healthcare provider advised a specific CRC test (FOBT, sigmoidoscopy, colonoscopy). We
included respondent characteristics, CRC history and healthcare provider advised a specific
CRC test to compare our results with previous studies.
2.3. Data Analysis
We combined data from the three survey modes because there were no differences in
validity estimates by mode [13]. We computed concordance (i.e., percentage agreement),
sensitivity, specificity, and report-to-records ratio for any CRCS test (FOBT, sigmoidoscopy
and/or colonoscopy) by subgroup. Subgroups with less than 5 in a cell for their respective 2
× 2 tables were collapsed into an adjacent category if possible; those subgroups that could
not be collapsed were excluded. Two-sided 95% confidence intervals were calculated for all
measures. Analyses by each CRC test were attempted but yielded unstable estimates for
multiple subgroups because cells (<5) could not be meaningfully collapsed.
Tisnado et al.’s [21] criteria for evaluating sensitivity and specificity of ambulatory care
services were used to assess concordance, sensitivity, and specificity: >0.9 denotes excellent
agreement, >0.8 to <0.9 denotes good agreement, >0.7 to <0.8 denotes fair agreement and
<0.7 denotes poor agreement. The report-to-records ratio is a measure of net bias in test
reporting [22]. Values >1.0 indicate over-reporting, and values <1.0 indicate under-
reporting; 95% confidence intervals were used to determine the precision of over- or under-
reporting. All data were analyzed using Microsoft Excel 2007 and Inter-cooled Stata version
9.0 (Stata Corporation College Station, TX).
3. RESULTS
Most respondents were 51 – 64 years old (81.2%), female (65.8%), married or living with a
partner (74.2%), and college educated (54.6%); 59.4% were non-Hispanic white and 26.4%
were African American. Approximately 11.3% had a family history of CRC. Most (93.2%)
had a clinic visit within the last year, and 86.8% had more clinic visits within the past 5
years. Only 14.5% had more than 5 visits outside the clinic within the past 5 years. Most
reported having had FOBT, sigmoidoscopy and/or colonoscopy in the past (61.5%).
Concordance was mostly good, except for the following subgroups: respondents aged 65
years and older, those with a family history of CRC, those with 5 or less visits to the clinic,
and those with more than 5 visits outside the clinic (Table 1). For sensitivity, estimates were
excellent or good except for respondents whose healthcare provider did not advise a specific
CRCS test. In contrast, specificity estimates were mostly fair but were poor for several
subgroups, including those aged 65 years and older, male, college graduates, positive family
history of CRC, more than 5 visits to an outside provider in the past 5 years, and whose
provider advised a specific CRCS test. Report-to-records ratios indicated over-reporting for
respondents aged 65 years and older and those with more than 5 visits to an outside provider
within the past 5 years.
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Our finding that older patients over-reported any CRCS test within guidelines was similar to
Partin et al.’s [12], suggesting that researchers and providers may need to rely on other
sources of information to ascertain screening history for this subgroup. Other published
studies on correlates of accuracy of self-reported CRCS tests are limited primarily to socio-
demographics and show little consistency in the validity measures reported [5,6,8–12, 19].
Six studies used one or more of the four validity measures as our study-concordance [8–
12,19], sensitivity [8–10,12,19], specificity [8–10,12,19] and/or report-to- records ratio [12]
to determine whether age [10–12], race/ethnicity [8,9,11,12,19], sex [9,12], education
[11,12], marital status [12] and family history of CRC [11,12] were associated with accuracy
of self-reported FOBT [8–11,19], sigmoidoscopy [8,9,19], colonoscopy [8,19] and/or any
CRCS [12]. Inconsistencies in findings among these studies [8–10,12,19] are likely due to
variation in the populations studied, the time interval used to assess recall, and the CRCS
guidelines used to measure validity which limited comparability of our findings to only one
study [12]. Study samples included carpenters [10], patients from health maintenance
organizations [8,9], primary care clinics [19] and users of the Veteran’s Administration
healthcare facilities [12]. The time interval used to compare self-reported CRCS behaviors
with medical records also differed across studies, particularly for FOBT where the time
intervals included one [10,12,19], two [9], and five years [8]. Only two studies [12,19] used
evidence-based guidelines to assess validity of self-reported CRCS.
To our knowledge, this is the first study to examine whether accuracy of self-reported CRCS
varied by healthcare utilization. Patients who had more than 5 visits to an outside provider in
the past 5 years may over-report CRCS. For patients who reported seeing outside providers,
we were able in most instances to contact those providers and verify self-reports; however,
patients may not have provided complete information about the medical care they received
elsewhere which might explain why specificity and concordance were poor. Nevertheless,
providers need to be diligent in taking medical histories among patients using multiple
sources of medical care. Further, there is a need for better patient-provider communication
about CRCS as evidenced by the low percentage of respondents, without a provider advising
a specific CRCS test, who correctly reported having any CRCS test when they had it
(sensitivity) and low percentage of respondents, whose provider advised a specific CRCS
test, that correctly reported not having any CRCS test and did not (specificity).
Strengths of our study include the use of a standardized questionnaire to ascertain self-
reported screening, inclusion of covariates that have not been examined previously, a
diverse sample with a large number of African Americans, a relatively stable patient
population where almost all endoscopies were done on site, and follow-up with outside
providers to verify self-reports in the few cases where CRCS was done elsewhere.
Nevertheless, the generalizability of our findings is limited because our sample consisted of
insured men and women receiving care primarily from one practice.
To our knowledge, this is the most comprehensive assessment to date of the accuracy of
self-reported measures of CRCS by respondent characteristics and healthcare utilization
factors. Our findings show that self-report of any CRCS test within guidelines, as measured
by concordance, sensitivity, and report-to-records ratio, is reasonably accurate across
subgroups. However, more research is needed to replicate these findings in diverse settings
and populations to better understand subgroup differences and improve measures of CRC.
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